Patient-Derived Xenograft (Pdx) Models, Applications and Challenges in Cancer Research

Patient-Derived Xenograft (Pdx) Models, Applications and Challenges in Cancer Research Publisher Pubmed

Abdolahi S¹ ; Ghazvinian Z² ; Muhammadnejad S³ ; Saleh M² ; Asadzadeh Aghdaei H¹ ; Baghaei K¹

Source: Journal of Translational Medicine Published:2022

Abstract

The establishing of the first cancer models created a new perspective on the identification and evaluation of new anti-cancer therapies in preclinical studies. Patient-derived xenograft models are created by tumor tissue engraftment. These models accurately represent the biology and heterogeneity of different cancers and recapitulate tumor microenvironment. These features have made it a reliable model along with the development of humanized models. Therefore, they are used in many studies, such as the development of anti-cancer drugs, co-clinical trials, personalized medicine, immunotherapy, and PDX biobanks. This review summarizes patient-derived xenograft models development procedures, drug development applications in various cancers, challenges and limitations. © 2022, The Author(s).

Related Docs

View other Related Docs

1. The Progressive Trend of Modeling and Drug Screening Systems of Breast Cancer Bone Metastasis, Journal of Biological Engineering (2024)

2. Evaluation of the Treatment Strategies on Patient-Derived Xenograft Mice of Human Breast Tumor, European Journal of Pharmacology (2020)

3. A Review of Animal Models Utilized in Preclinical Studies of Approved Gene Therapy Products: Trends and Insights, Laboratory Animal Research (2024)

Experts (# of related papers)

View all Related Experts

Javad Verdi (4)

Mohammad Abdollahi (3)

Style	Citing Format
MLA	Abdolahi S, et al.. "Patient-Derived Xenograft (Pdx) Models, Applications and Challenges in Cancer Research." Journal of Translational Medicine, vol. 20, no. 1, 2022, pp. -.
APA	Abdolahi S, Ghazvinian Z, Muhammadnejad S, Saleh M, Asadzadeh Aghdaei H, Baghaei K (2022). Patient-Derived Xenograft (Pdx) Models, Applications and Challenges in Cancer Research. Journal of Translational Medicine, 20(1), -.
Chicago	Abdolahi S, Ghazvinian Z, Muhammadnejad S, Saleh M, Asadzadeh Aghdaei H, Baghaei K. "Patient-Derived Xenograft (Pdx) Models, Applications and Challenges in Cancer Research." Journal of Translational Medicine 20, no. 1 (2022): -.
Harvard	Abdolahi S et al. (2022) 'Patient-Derived Xenograft (Pdx) Models, Applications and Challenges in Cancer Research', Journal of Translational Medicine, 20(1), pp. -.
Vancouver	Abdolahi S, Ghazvinian Z, Muhammadnejad S, Saleh M, Asadzadeh Aghdaei H, Baghaei K. Patient-Derived Xenograft (Pdx) Models, Applications and Challenges in Cancer Research. Journal of Translational Medicine. 2022;20(1):-.
BibTex	@article{ author = {Abdolahi S and Ghazvinian Z and Muhammadnejad S and Saleh M and Asadzadeh Aghdaei H and Baghaei K}, title = {Patient-Derived Xenograft (Pdx) Models, Applications and Challenges in Cancer Research}, journal = {Journal of Translational Medicine}, volume = {20}, number = {1}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Abdolahi S AU - Ghazvinian Z AU - Muhammadnejad S AU - Saleh M AU - Asadzadeh Aghdaei H AU - Baghaei K TI - Patient-Derived Xenograft (Pdx) Models, Applications and Challenges in Cancer Research JO - Journal of Translational Medicine VL - 20 IS - 1 SP - EP - PY - 2022 ER -

Science Communicator Platform

Authors

Abstract